Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01057433 · ClinicalTrials.gov registry record · Phase 4
Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin
A Phase 4 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT01057433 is a Phase 4 study that has completed, run by Kowa Research Institute. The registered enrollment target is 24 participants.
The verdict
NCT01057433, a Phase 4 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
This is a Phase 4, single center, open label, fixed-sequence, 2-way drug-drug interaction study.
Interventions
- DRUG Lopinavir/ritonavir
- DRUG Pitavastatin (NK-104)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01057433
The ClinicalTrials.gov registry entry for NCT01057433 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lopinavir/ritonavir is the first listed.
NCT01057433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01057433 about?
NCT01057433 is a clinical study titled "Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin". This is a Phase 4, single center, open label, fixed-sequence, 2-way drug-drug interaction study.
What is the current status of trial NCT01057433?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2010-01. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01057433?
The interventions under investigation include: Lopinavir/ritonavir (DRUG), Pitavastatin (NK-104) (DRUG).
Who is sponsoring clinical trial NCT01057433?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.